The primary capital raised in this round will be utilised towards organic growth in India and taking the proven business model of NephroPlus to other markets, starting with South East Asia, Investcorp said in a statement.from Moneycontrol Business News https://ift.tt/37ENX3p
No comments:
Post a Comment